Skip to content
Search

Latest Stories

Pharmacies to offer blood pressure checks from October, says NHS England

With a new deal, all NHS pharmacies in England will be able to offer blood pressure checks to people aged 40 and over from October, saving thousands of lives.

As per government estimates, over the next five years 3,700 strokes and 2,500 heart attacks could be prevented as a result of the tests and around 2,000 lives could be saved.


Predictions also show that if 2.5 million people get their blood pressure checked in this way, an additional 250,000 people could receive lifesaving treatment for hypertension.

The NHS began piloting the checks in autumn 2019, and the full rollout will start from October this year.

NHS national medical director Professor Stephen Powis said the checks will result in "more rapid detection of killer conditions and quicker treatment for patients who need it".

He added: "Pharmacies are in the heart of communities and so they are ideally placed to provide these convenient checks - so, if you are worried about your health, please do get tested - it could save your life.

"The NHS Long Term Plan aims to crack down on killer conditions and this action by pharmacy teams will go a long way in helping us achieve our ambitions of saving more lives."

Under the deal, pharmacists will case-find and offer blood pressure tests to people showing symptoms, provide clinical and lifestyle advice or referral, and record the data, joining up services and treatment with GPs and other local services, to speed up access to care.

Local chemists will also play a part in NHS smoking cessation services by offering advice and care to smokers who have recently been discharged from hospital.

Besides, patients will receive support sessions over 12 weeks with a trained member of the pharmacy team.

Health minister Lord Bethell said: “I want to say a huge thank you to pharmacists for their hard work and commitment to delivering more services to their patients, helping support a healthy nation.

“Pharmacists are the first port of call for minor conditions and it is really encouraging to see even more health services being led from pharmacies, many of which are at the heart of local communities and easy to access."

He suggested that everyone should sign up for these services when they come online from October.

Dr Shahed Ahmad, national clinical director for cardiovascular disease prevention, said community pharmacists are "ideally placed to deliver this life-saving work".

He added: "Cardiovascular disease claims 136,000 lives a year and is a major cause of health inequalities, with about half of heart attacks and strokes are associated with high blood pressure.

"The detection and control of high blood pressure is one of the best things we can do to save lives and reduce health inequalities."

Dr Keith Ridge, chief pharmaceutical officer at NHS England, said: "Pharmacy teams have already played an important part in the NHS Covid vaccination programme, the biggest and most successful in the health service's history, and - with this new service being rolled out across the country - they will have a vital new role in delivering life-saving blood pressure checks in the heart of our communities."

Pharmacist Helen Williams, who's the national specialty adviser for cardiovascular disease prevention at NHS England and NHS Improvement, said: “As a pharmacist, I am delighted that this service is being rolled out across England. Community pharmacies are ideally placed to deliver blood pressure checks, being accessible within local communities and regularly used by most adults.”

More For You

Prostate cancer: At-home saliva test could save NHS £500 million annually

PRS saliva test can identify prostate cancer that was missed by an MRI scan

Photo credit: gettyimages

Prostate cancer: Spit test better than blood test in spotting men at highest risk

A simple at-home spit test could help detect prostate cancer earlier, saving the NHS around £500 million a year, according to new research published in the New England Journal of Medicine.

Funded by the National Institute for Health and Care Research (NIHR), the study found that the DNA-based saliva test was more accurate than the current prostate-specific antigen (PSA) blood test in identifying men at risk of developing prostate cancer.

Keep ReadingShow less
RPS launches innovative new learning resources for members

With RPS Learn, pharmacists can develop a new skill or improve their understanding of practice or a clinical topic.

Gettyimages

RPS launches new learning resources to boost career development for members

The Royal Pharmaceutical Society (RPS) has launched a new online learning platform designed to support the practice, development and career advancement of its members.

The new platform, called RPS Learn, offers a diverse range of bite-size learning content, available on-demand, catering to all levels — from introductory to advanced and specialist —combining new content with RPS's renowned expertise in education and training to achieve excellence for learners.

Keep ReadingShow less
NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less